ROCKVILLE, Md., May 9, 2017 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced that its joint venture, ReGenTree LLC, presented the…
May 09, 2017 at 07:47PM
from
No comments:
Post a Comment